Sasan Amirhassankhani

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Percutaneous Radiofrequency Ablation for Bosniak III-IV Cysts: A 5-Year Institutional Experience.

Percutaneous Radiofrequency Ablation for Bosniak III-IV Cysts: A 5-Year Institutional Experience.

Journal: Journal of endourology

Published: March 02, 2026

Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World Study.

Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World Study.

Journal: Pigment cell & melanoma research

Published: April 22, 2025

The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma.

The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma.

Journal: Cancers

Published: August 08, 2023

A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors.

A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors.

Journal: Frontiers in immunology

Published: April 02, 2023

Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center.

Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center.

Journal: Medicina (Kaunas, Lithuania)

Published: November 28, 2022

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile.

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile.

Journal: Biomedicines

Published: August 21, 2022

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.

Journal: Cancer immunology, immunotherapy : CII

Published: July 16, 2022

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.

Journal: Frontiers in immunology

Published: June 20, 2022

Transdiaphragmatic autopsy approach: our experience in the Sars-CoV-2 pandemic.

Transdiaphragmatic autopsy approach: our experience in the Sars-CoV-2 pandemic.

Journal: Virchows Archiv : an international journal of pathology

Published: May 14, 2022

Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era.

Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era.

Journal: Journal of translational medicine

Published: May 18, 2021

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer.

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer.

Journal: Cancers

Published: January 07, 2021

Primary squamous cell carcinoma of major salivary gland: "Sapienza Head and Neck Unit" clinical recommendations.

Primary squamous cell carcinoma of major salivary gland: "Sapienza Head and Neck Unit" clinical recommendations.

Journal: Rare tumors

Published: August 28, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026